| Date | Title | Description |
| 01.05.2024 | Raheem Mostert, Miami Dolphins, Melanoma Supporter and Advocate, Gets Naked for Melanoma Awareness Month | #GetNaked Campaign Spokesperson, Raheem Mostert, Miami Dolphins Running Back, melanoma supporter and advocate
The Melanoma Research Foundation (MRF) is pleased to announce the official launch of its annual award-winning #GetNaked campaign i... |
| 17.04.2024 | National Comprehensive Cancer Network Awards Champions for Excellence and Outstanding Contributions in Cancer Care | Dr. Shaji Kumar, Darcie Green, and members of the NCCN Covid-19 Vaccine Advisory Committee honored for their contributions to improving cancer care over the years; Donna Black named NCCN Employee of the Year.
PLYMOUTH MEETING, Pa., April 17... |
| 25.03.2024 | Health | Researchers unveil new blood test that detects colon cancer | Elise Takahama | (TNS) The Seattle Times
Researchers at the Fred Hutchinson Cancer Center have unveiled a new type of blood test used to detect colorectal cancer, with high hopes not only in its ability to reduce barriers to testing for thi... |
| 22.03.2024 | What’s next for the coronavirus? | MICHAEL B. THOMAS/THE NEW YORK TIMES
Wastewater samples, which can be used to identify mutations in an area before they are detected in people, are seen at the University of Missouri in Columbia, in May 2021. Scientists studying COVID-19’s ... |
| 11.03.2024 | Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights | WORCESTER, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies i... |
| 20.07.2023 | Affini-T Therapeutics shutting down Seattle lab | Affini-T Therapeutics, a cell therapy company spun out of Fred Hutchinson Cancer Research Center that aims to treat solid tumors, is closing its Seattle lab.
Multiple impacted employees posted on LinkedIn about the Seattle office shutting d... |
| 28.06.2023 | The CDC says that if you have a mystery fever this summer, there's a chance it could be malaria | Health The CDC says that if you have a mystery fever this summer, there's a chance it could be malaria
Hilary Brueck
2023-06-28T18:56:24Z
Share icon An curved arrow pointing right.
Share
Facebook Icon The letter F.
Facebook Email icon An en... |
| 08.06.2023 | Encouraging First-in-Human Results for a Promising HIV Vaccine | Cross-posted from: NIH Director’s Blog
Posted on June 6th, 2023 by Lawrence Tabak, D.D.S., Ph.D. Researchers used a customized nanoparticle (top left) to learn more about guiding the immune system to mount a desired robust response, the typ... |
| 11.04.2023 | Tech Moves: Adaptive Biotechnologies COO departing; Sana adds leaders; and more | Mark Adams. (Adaptive Photo)
— Mark Adams is stepping down as chief operating officer of Adaptive Biotechnologies, the company said today in a regulatory filing.
Adams joined the Seattle-based biotech giant more than three years ago. The fi... |
| 28.02.2023 | The Women Working To Solve The Home Health Caregiver Crisis | Home Healthcare Worker Trainingc/o Madeline Sterling |
| 21.12.2022 | The effects of a healthy diet on cancer progression | App Store Preview
App & Play Stores
Weight Loss Buddy
For some slow-growing cancers, diagnosed patients lacking additional risk factors might opt to follow active surveillance instead of curative treatments
You can’t help someone up a h... |
| 20.12.2022 | Washington Research Foundation Awards Additional $1M to Fred Hutchinson Cancer Center Supporting Innovative Technology Commercialization Research in Life Sciences | “This program is enabling researchers at Fred Hutch to take their discoveries one step closer to becoming therapeutic products and interventions that could potentially transform how diseases are treated.” Hilary Hehman, M.S., J.D., vice pre... |
| 24.10.2022 | Tech Moves: Madrona hires former Bezos technical advisor; Seattle Children’s names COO | Wei Gao (left) and Anna Baird. (Madrona Photos)
— Seattle-based firm Madrona Venture Group appointed Wei Gao as venture partner and Anna Baird as operating partner.
Gao was most recently chief operating officer at Hopin, a London-based even... |
| 21.10.2022 | As links to MS deepen, researchers accelerate efforts to develop an Epstein-Barr vaccine | Maybe you’ve never heard of the Epstein-Barr virus. But it knows all about you.
Chances are, it’s living inside you right now. About 95% of American adults are infected sometime in their lives. And once infected, the virus stays ... |
| 18.08.2022 | Startup detects COVID-19 using spit, light, and a computer built to analyze patterns | Pattern Computer’s ProSpectral device for detecting COVID-19. (Pattern Computer Photo)
A Seattle-area startup called Pattern Computer is developing a rapid COVID-19 test based on patterns in light from spit, one of several projects moving a... |
| 10.08.2022 | Fred Hutch spinout lands $10M for precision test to guide cancer treatment, develop drugs | SEngine CEO and chief scientific officer Carla Grandori. (SEngine Photo)
Seattle startup SEngine Precision Medicine has raised $10 million to propel drug discovery and development and advance its test that tailors drugs to cancer patients.
... |
| 28.07.2022 | Seattle biotech startup Ozette lands $26M from Microsoft, Madrona, others to analyze immune cells | Ali Ansary (left) Ozette CEO and Greg Finak, chief technology officer. (Ozette Photos)
The news: Single cell analysis startup Ozette Technologies, with deep roots in the Seattle academic and startup community, has raised $26 million. The co... |
| 22.03.2022 | Fred Hutch spinout Affini-T Therapeutics lands $175M for cell therapies to treat solid tumors | From left: Affini-T scientific co-founders and Fred Hutch investigators Philip Greenberg, Aude Chapuis, and Thomas Schmitt. (Fred Hutch Photos)
New funding: Affini-T Therapeutics, a cell therapy company spun out of Fred Hutchinson Cancer Re... |
| 14.01.2022 | Vir to extend COVID-19 treatment approach to HIV, malaria with $50M from Gates Foundation | The Bill & Melinda Gates Foundation has committed $40 million in equity investment and $10 million in grant funding to Vir Biotechnology for the development of therapies against HIV and Malaria, Vir announced Friday. San Francisco-based... |
| 13.01.2022 | Juno co-founder launches ambitious new startup with Fred Hutch colleagues to treat cancer | From left: Affini-T scientific co-founders and Fred Hutch investigators Philip Greenberg, Aude Chapuis, and Thomas Schmitt. (Fred Hutch Photos)
A new cell therapy company is on the block, propelled by powerhouse scientific co-founders from ... |
| 14.07.2021 | Tom Lynch moves to restructure Fred Hutch as academia, industry continue to push cell therapy into solid tumors | By the time former Bristol Myers Squibb CSO Tom Lynch stepped in to run the Fred Hutch Cancer Research Center last year, both the potential and limits of the institute’s preclinical research had become clear.
The institute... |
| 04.05.2021 | A doctor trained nurse practitioners to do colonoscopies. Critics say his research exploited Black patients | At a time when medical researchers are under pressure to increase diversity in clinical trials, a Johns Hopkins study is sparking outrage among some physicians because of its large number of Black patients.
The controversy has stoked concer... |
| 20.04.2021 | Startup of the Year: Vote for the hottest up-and-coming company at the GeekWire Awards | The five finalists for this year’s Startup of the Year category at the GeekWire Awards reflect the strength of the entrepreneurial ecosystem in Seattle and the greater Pacific Northwest.
Common Room; Ozette; SeekOut; Shelf Engine; and Strik... |
| 02.03.2021 | Presage Biosciences raises $13M and inks new deal with Merck for cancer drug tests | Presage CEO Richard Klinghoffer. (Presage Photo)
New funds, new partners: Seattle’s Presage Biosciences announced $13 million in funding as well new collaborations with biotech giant Merck and California-based Maverick Therapeutics. Presage... |
| 19.02.2021 | ‘A massive gap in information’: Most vaccine clinical trials fail to report data on participants’ ethnicity or race | An analysis of the demographics of a decade’s worth of vaccine clinical trials has found that Black Americans, Latinos, American Indians, and Alaskan Natives, as well as people age 65 and older, were underrepresented as participants within ... |
| 16.02.2021 | Fred Hutch biotech spinout Ozette raises $6M from Madrona, AI2, Vulcan | Ozette co-founders Dr. Ali Ansary (left), CEO, and Greg Finak, CTO. (Ozette Photos)
New funding: Ozette, a biotech company that last year spun out of the Fred Hutchinson Cancer Research Center and was incubated at the Allen Institute for Ar... |
| 12.02.2021 | The coronavirus is going to stick around forever. Get ready for the new normal. | Experts agree: The novel coronavirus isn’t going anywhere anytime soon. Samantha Lee/Insider
The spread of coronavirus variants means COVID-19 will likely be around forever.
People might require regular booster shots to fight new variants o... |
| 12.02.2021 | The coronavirus is going to stick around forever. Get ready for the new normal. | Samantha Lee/Insider
The spread of coronavirus variants means Covid-19 will likely be around forever.
People might require regular booster shots to fight new variants of the coronavirus.
But experts caution that it's impossible to vaccinate... |
| 11.02.2021 | Fred Hutch, Univ. of Washington biotech spinout Ensoma launches with $70M in funding | Dr. Hans-Peter Kiem of the Fred Hutchinson Cancer Research Center. (Fred Hutch Photo)
New spinout: Boston-based biotech startup Ensoma launched Thursday and announced a $70 million Series A funding round. The company is built on technology ... |
| 12.01.2021 | Tech Moves: Expedia board director Skip Battle resigns; Madrona promotions; Vacasa’s new CFO | Skip Battle. (Global Ventures Photo)
— George “Skip” Battle, the former CEO of AskJeeves, has resigned from Expedia Group’s board of directors. He originally joined the travel company’s board in 2005.
Battle is a longtime board member at Ne... |
| 29.12.2020 | First U.S. Case Of Covid-19 Variant Reported In Colorado: What Does This Mean? | FORT COLLINS, COLORADO - NOVEMBER 14: Gina Harper, clinical coordinator with pharmacy, measures out ... [+] the exact amount of the Covid-19 vaccine for a dose before it is administered to the first patients in Colorado at UC Health Poudre ... |
| 01.09.2020 | Seattle biotech startup led by Fred Hutch, Adaptive vets raises $16M for rapid drug development tech | Lumen Chief Science Officer Jim Roberts (left) and CEO Brian Finrow. (Lumen Photo)
Lumen Bioscience today announced a $16 million Series B round to help support its novel approach to rapid and low-cost drug development.
The company has come... |
| 06.03.2020 | Study Says Travel Restrictions Can Delay, but Can’t Defeat a Global Coronavirus Outbreak | Comparisons of the real-world spread of the COV-19 coronavirus with computer models indicate that the travel restrictions imposed by authorities in China and other nations have delayed the progress of the outbreak by a matter of days or wee... |
| 04.02.2020 | HIV vaccine remains Holy Grail as Sanofi/GSK regimen disappoints in large study | An HIV vaccine regimen comprising experimental components supplied by Sanofi and GlaxoSmithKline has been declared ineffective, underscoring the difficulty of this undertaking and raising the stakes for a mosa... |
| 02.10.2019 | Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors | SEngine tests how safe and effective various cancer drugs are against a patient’s tumor. Each well in the tray pictured above could hold a tiny version of a tumor and a unique drug or combination of drugs. (SEnginge Photo)
Seattle startup S... |
| 11.08.2019 | How MoviePass burned through millions, JPMorgan's power players, and Instagram's privacy practices | Hollis Johnson/Business Insider
Advertisement
Hello!
In a break from the usual format, I wanted to highlight a selection of our best reporting from across the newsroom, rather than focus on a specific theme. The range and depth of our repor... |
| 19.07.2018 | Johnson & Johnson launches life sciences incubator for Philadelphia area | The goal of the program is to identify and accelerate the development of early-stage healthcare businesses from the Philadelphia region’s life science industry in areas like pharmaceuticals, medical devices, consumer and health technologies... |
| 10.05.2018 | Revealed: Winners of the 2018 GeekWire Awards | Trish Millines Dziko, co-founder and executive director of Technology Access Foundation, accepts the Geeks Give Back award as TAF’s Tyrone Cunningham and Shaunte Nance-Johnson and Bank of America’s Kim Vu look on. (GeekWire photos / Kevin L... |
| 20.02.2017 | Critics of experimental cancer therapy just don’t get it | Cancer killed my young son, Zach. He fought hard against it for four years. His experience, his bravery, and most of all his absence make me question some of the critics of CAR-T therapy, a cutting-edge form of cancer immunotherapy. They sa... |
| 29.11.2016 | Nohla Therapeutics raises $43.5M to develop universal donor cellular therapies | The money will help to advance Nohla’s two lead programs (NLA-101 and NLA-102) that were created from the company’s platform that has its roots in the Fred Hutchinson Cancer Research Center. The technology was spun out from the Hutch in Sep... |
| 02.11.2016 | Financial toxicity: 1 in 3 cancer patients have to turn to friends or family to pay for care | Maria (not her real name) was terrified when her 5-year-old son, Rafe, was diagnosed with a rare form of cancer. She worried about his chances of survival and the side effects of the proposed treatment. What she didn’t anticipate was the fi... |
| 04.10.2016 | Juno CEO: Washington state biotech is ‘going backwards,’ needs support from Olympia to catch up | Juno Therapeutics CEO Hans Bishop speaking at the 2016 GeekWire Summit. Photo by Dan DeLong for GeekWire
While Washington state’s biotech industry is on the up and up, it still lags far behind hubs like San Francisco and Cambridge, Mass.
Wa... |
| 11.08.2016 | Seattle biotech entrepreneur Ron Berenson raising cash for new startup | Ronald Berenson, serial entrepreneur, is heading up DMD Therapeutics. Photo: Conrado Tapado, CoMotion.
Ron Berenson has another biotechnology startup in the works, a new company by the name of DMD Therapeutics.
The Seattle-based company rec... |
| 27.07.2016 | BioMed Realty opening new biotech startup space in lab-starved Seattle | BioMed Realty recently finished The Labs @ 201 Elliott, a startup space for biotech companies. Credit: BioMed Realty.
Startup, co-working and incubator spaces are proliferating throughout the Puget Sound region. But Seattle isn’t just a tec... |
| 03.12.2015 | Fred Hutchinson Cancer Research Center spins out disease-fighting biotech startup Nohla Therapeutics | Nohla Therapeutics chief medical officer Colleen Delaney.
Nohla Therapeutics just became the latest biotech startup to come out of the Fred Hutchinson Cancer Research Center. Like spinouts before it, Nohla is already well on its way to beco... |
| 04.08.2015 | GeekWire Summit: Dave McClure and Brady Forrest join the lineup for our biggest event ever | The GeekWire Summit is less than two months away, on Oct. 1 and 2 in Seattle, and today we’re excited to announce two fantastic additions to the lineup: Outspoken Silicon Valley investor Dave McClure of 500 Startups will appear in a joint s... |
| 03.03.2015 | 2Morrow recruiting for second clinical trial of smoking cessation app program with employers | 2Morrow is embarking on a second study for a smoking cessation smartphone app it created with the Fred Hutchinson Cancer Center. It follows a clinical trial last year that showed higher quit rates than for Quitguides distributed by state pr... |
| 03.12.2013 | Cancer research startup Juno Therapeutics raises $120M in massive series A financing | In one of the largest series A venture capital deals this year in the biotechnology sector, Seattle-based Juno Therapeutics has landed $120 million in startup financing in a deal led by Arch Venture Partners and the Alaska Permanent Fund.
T... |
| - | Invisible in the data: Broad ‘Asian American’ category obscures health disparities | They have roots in 50 countries that cover more than half of the globe’s surface. They make up more than 60% of the world’s population. They speak more than 100 different languages. Yet in medical research and public health in the United St... |
| - | Nohla Therapeutics raises $43.5M to develop universal donor cellular therapies | Nohla Therapeutics, a Seattle-based biotech company announced Tuesday that it has raised $43.5 million in a Series A funding round.
The round was led by ARCH Venture Partners, a new investor in Nohla. Others who participated were 5AMVenture... |
| - | Scientists May Be Closer to Effective HIV Vaccine | FRIDAY, Dec. 2, 2022 (HealthDay News) -- It's thought that for an HIV vaccine to be widely effective, it will have to spur the body to make special antibodies that can neutralize a broad range of HIV strains. Now scientists say they have ta... |
| - | The diagnostic dilemma of co-infections requires novel solutions | Vector flat blood laboratory icon illustration. Magnifier glass zoom blood drop cell. Concept of DNA, HIV diagnosis lab. Design element for poster, flyer, card, banner, ui
Covid-19 patients with co-infections suffer longer hospital stays an... |
| - | Extraordinary love of baseball fueled longtime front-office career | In letters and emails to friends and acquaintances, Lewis “Lew” Matlin would ritually close with the phrase, “Be of good cheer!”
For him, family, the sport of baseball and the relationships that developed around it in a career that spread a... |
| - | 2Morrow recruiting for second clinical trial of smoking cessation app program with employers | 2Morrow is embarking on a second study for a smoking cessation smartphone app it created with the Fred Hutchinson Cancer Center. It follows a clinical trial last year that showed higher quit rates than for Quitguides distributed by state pr... |
| - | Johnson & Johnson launches life sciences incubator for Philadelphia area | The University of Pennsylvania’s startup incubator is getting a boost from a big pharmaceutical company.
Drugmaker Johnson & Johnson said Tuesday that it had made a deal with the university to launch the JPOD @ Philadelphia, within the ... |
